Exane Derivatives’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$204 Hold
1
﹤0.01% 674
2022
Q1
$211 Hold
1
﹤0.01% 959
2021
Q4
$240 Sell
1
-369
-100% -$88.6K ﹤0.01% 816
2021
Q3
$105K Buy
370
+369
+36,900% +$104K 0.03% 506
2021
Q2
$352 Sell
1
-9
-90% -$3.17K ﹤0.01% 960
2021
Q1
$2.8K Hold
10
﹤0.01% 638
2020
Q4
$2.45K Hold
10
﹤0.01% 592
2020
Q3
$2.84K Sell
10
-1,415
-99% -$401K ﹤0.01% 518
2020
Q2
$381K Buy
1,425
+1,412
+10,862% +$378K 0.1% 162
2020
Q1
$4.11K Hold
13
﹤0.01% 436
2019
Q4
$3.81K Sell
13
-1,486
-99% -$435K ﹤0.01% 432
2019
Q3
$349K Hold
1,499
0.06% 182
2019
Q2
$350K Sell
1,499
-998
-40% -$233K 0.06% 196
2019
Q1
$590K Buy
2,497
+2,189
+711% +$517K 0.12% 134
2018
Q4
$92.7K Buy
308
+135
+78% +$40.6K 0.02% 299
2018
Q3
$61.4K Sell
173
-302
-64% -$107K 0.01% 339
2018
Q2
$139K Sell
475
-1,560
-77% -$455K 0.02% 269
2018
Q1
$549K Buy
2,035
+1,293
+174% +$349K 0.11% 151
2017
Q4
$236K Buy
742
+32
+5% +$10.2K 0.04% 208
2017
Q3
$222K Buy
710
+632
+810% +$198K 0.04% 172
2017
Q2
$21.2K Sell
78
-6
-7% -$1.63K ﹤0.01% 327
2017
Q1
$23K Sell
84
-91
-52% -$24.9K 0.01% 295
2016
Q4
$49.6K Sell
175
-8,420
-98% -$2.39M 0.01% 270
2016
Q3
$2.69M Buy
8,595
+8,314
+2,959% +$2.6M 0.4% 54
2016
Q2
$67.9K Buy
281
+9
+3% +$2.18K 0.01% 262
2016
Q1
$70.8K Sell
272
-212
-44% -$55.2K 0.01% 237
2015
Q4
$148K Buy
484
+168
+53% +$51.5K 0.02% 156
2015
Q3
$92.2K Buy
316
+266
+532% +$77.6K 0.01% 204
2015
Q2
$20.2K Hold
50
﹤0.01% 301
2015
Q1
$21.1K Sell
50
-200
-80% -$84.4K ﹤0.01% 314
2014
Q4
$84.9K Buy
+250
New +$84.9K 0.01% 264